Access to Treatment for Hepatitis B Virus Infection - Worldwide, 2016

Among persons living with HBV worldwide, approximately 27 million (10.5%) were aware of their infection, including 4.5 million (16.7%) who were on treatment. In 2017, all but two low- and middle-income countries could legally procure generic entecavir or tenofovir, the medicines active against HBV infection.
Source: PHPartners.org - Category: International Medicine & Public Health Source Type: news